Antiplatetelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Recruiting
- Conditions
- Acuut coronair syndroomAcute coronary syndrome
- Registration Number
- NL-OMON20101
- Lead Sponsor
- Vereniging Cardiologen Club RijnmondEli Lilly NederlandGrootslag 1-5, P.O box 379NL - 3991 RA HoutenTHE NETHERLANDSTel: +31 30 602 58 37 Fax: +31 30 602 58 88 Mob: +31 6 5382 6188
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 4000
Inclusion Criteria
1. Diagnosis with NSTE-ACS or STEMI and treated with PCI during index hospitalization;
2. Age above 18 years.
Exclusion Criteria
Intolerance or allergy for aspirin, ticlopidine, clopidogrel or prasugrel.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Composite of all-cause mortality and nonfatal myocardial infarction.
- Secondary Outcome Measures
Name Time Method 1. All cause mortality;<br /><br>2. Cardiovascular death;<br /><br>3. Non fatal myocardial infarction;<br /><br>4. Stroke;<br /><br>5. Target vessel revascularization (TVR);<br /><br>6. Stent thrombosis;<br /><br>7. MACE (CV death/non-fatal MI/TVR);<br /><br>8. Incidence of non-CABG-related TIMI major bleeding.